Xeris Biopharma Holdings, Inc.XERSNASDAQ
LOADING
|||
PB Ratio: Discounted Valuation
Trending higher, below historical average, strong compound growth.
Left:
||||
Price-to-book ratio
Latest
-16.80
↓ 295% below average
Average (8y)
-4.25
Historical baseline
Range
High:12.75
Low:-47.71
CAGR
+39.6%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | -16.80 | +64.8% |
| 2023 | -47.71 | -1295.0% |
| 2022 | 3.99 | +64.2% |
| 2021 | 2.43 | -60.9% |
| 2020 | 6.21 | -51.3% |
| 2019 | 12.75 | +369.5% |
| 2018 | 2.72 | +483.0% |
| 2017 | -0.71 | +39.2% |
| 2016 | -1.17 | - |